| Issue 1072: August 20, 2013 TOP STORIES
IAC HANDOUTS VACCINE INFORMATION STATEMENTS FEATURED RESOURCES
JOURNAL ARTICLES AND NEWSLETTERS EDUCATION AND TRAINING
TOP STORIES New! Spanish-language translations of the 2013–14 influenza vaccine VISs now available IAC recently posted Spanish translations of the 2013–14 inactivated influenza vaccine (IIV) VIS, as well as the 2013–14 live, intranasal influenza vaccine (LAIV) VIS on its website. Please note: The 2013–14 influenza vaccine VISs will be available in several additional languages in the weeks ahead. IAC Express will announce the availability of translations as soon as they are ready. Related Links
IAC Spotlight! “Technically Speaking” column from IAC’s executive director covers practical topics in delivering vaccination services IAC is pleased to remind readers of its new web section on immunize.org. The web section is called Technically Speaking, and it features a monthly column about practical vaccine topics written by IAC’s executive director, Deborah L. Wexler, MD. The columns cover subject matter in vaccine delivery such as needle length, vaccine administration, cold chain, and immunization schedules. Dr. Wexler’s column made its debut in 2010 in Vaccine Update for Healthcare Providers, a monthly e-newsletter of the Children's Hospital of Philadelphia Vaccine Education Center (VEC), and is a regular feature.
Back to top CDC publishes report on human rabies case in South Carolina CDC published Human Rabies—South Carolina, 2011 in the August 16 issue of MMWR (pages 642–644). Two paragraphs from the article's editorial note are reprinted below. Bat exposure in the home was the likely source of infection in this case. Over 90% of domestically acquired human rabies cases reported in United States since 1995 have been linked epidemiologically to bats. Cryptogenic human rabies (i.e., cases where a definitive history of animal exposure is lacking) constitutes an increasing proportion of these bat-associated cases. Rabies virus transmission can occur from seemingly minor or unrecognized bites. A complete rabies virus exposure risk assessment is recommended for any person reporting potential exposure to a bat, even in the absence of a documented bite. The patient in this case sought information on bat removal but was not advised of the health risks associated with bat exposures. Lack of referral to guidance concerning health risks associated with bats living in the home was possibly a missed opportunity to prevent rabies infection. Because authority over wildlife management and animal bite reporting varies among states, citizens might reach out to diverse entities, including public health, animal control, law enforcement, or wildlife agencies, as initial points of contact for bat concerns. Provision of training, educational resources, and expert consultation to agencies, institutions, and organizations that provide assistance with wildlife concerns is a valuable public health service. Such service requires strong partnerships and clear communication among public health officials and diverse community partners. Back to top WHO reports on new case of avian influenza A(H7N9) virus infection in China On August 11, China's National Health and Family Planning Commission notified WHO of a new laboratory-confirmed case of human infection with avian influenza A(H7N9) virus. This is the first new confirmed case of human infection with avian influenza A(H7N9) virus since July 20, 2013. WHO has been informed of a total of 135 laboratory-confirmed human cases with the virus, including 44 deaths. WHO does not a currently recommend any travel or trade restrictions. Full WHO report Back to top IAC HANDOUTS New! All of IAC’s easy-to-read handouts on child, teen, and adult vaccination are now available in Spanish IAC’s recently developed easy-to-read handouts for parents and patients are now available in Spanish. The handouts promote vaccination against chickenpox, hepatitis A, hepatitis B, Hib, HPV, influenza, measles-mumps-rubella, meningococcal disease, pneumococcal disease, polio, rotavirus, shingles, and whooping cough-tetanus-diphtheria. They feature simple, friendly illustrations. Specifically developed to be short and non-medical, the handouts emphasize the dangers of the vaccine-preventable diseases listed above and the importance of vaccination. Download these new resources and give copies to parents and adult patients. These positive, succinct handouts will also be great for the back-to-school season! Handouts for parents of children
IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely. Back to top VACCINE INFORMATION STATEMENTS IAC posts new VIS translations in simplified Chinese, Burmese, Armenian, and Korean IAC recently posted a number of new translations to its VIS web section. New VIS translations in simplified Chinese
New VIS translations in Burmese
New VIS translation in Armenian View all Armenian VIS translations New VIS translation in Korean View all Korean VIS translations Related Links Visit IAC's VIS web section for VISs in more than 35 languages Back to top FEATURED RESOURCES Word of Mom campaign promotes vaccination In honor of the March of Dimes' 75th anniversary, the March of Dimes and sanofi pasteur have launched a new campaign titled Word of Mom: Celebrating 75 Years of Health Advice. The campaign aims to reach across generations to motivate mothers and caregivers to advocate for childhood, adolescent, and adult vaccinations. The Word of Mom campaign provides resources and advice, including health tips from moms across generations collected through a national survey. The website also offers a public service announcement and sample tweets and Facebook posts for organizations to share. Back to top Order IAC's popular full-size laminated versions of the 2013 U.S. immunization schedules today! IAC's laminated versions of the 2013 U.S. child/teen and adult immunization schedules are covered with a tough, washable coating that lets them stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. Each has six pages (i.e., three double-sided pages) and is folded to measure 8.5" by 11".
PRICING 1-4 copies: $7.50 each 5-19 copies: $5.50 each 20-99 copies: $4.50 each 100-499 copies: $4.00 each 500-999 copies: $3.50 each For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email admininfo@immunize.org You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page. Back to top JOURNAL ARTICLES AND NEWSLETTERS CDC publishes report on testing for chronic hepatitis C infection CDC published Locations and Reasons for Initial Testing for Hepatitis C Infection—Chronic Hepatitis Cohort Study, United States, 2006–2010 in the August 16 issue of MMWR (pages 645–648). The first paragraph of the article is reprinted below. Chronic hepatitis C virus (HCV) infection causes substantial morbidity and mortality in the United States. Testing and treatment of asymptomatic persons might avert progression to more advanced disease. In 1998, CDC published guidelines for HCV testing based on risk factors for infection; however, recent studies indicate that at least one half of all persons living with HCV infection in the United States are unaware of their infection status. To increase testing rates, in 2012 CDC recommended one-time testing of all persons born during 1945–1965. To better understand where and why persons with chronic HCV infection sought their initial testing, 2006–2010 data were analyzed from a survey conducted as part of the ongoing Chronic Hepatitis Cohort Study. Of 4,689 patients with HCV infection who responded to the survey, 60.4% reported that their initial HCV test occurred in a physician's office. CDC's risk-based indications (e.g., injection drug use and hemodialysis) were cited by 1,045 (22.3%) of the patients as reasons for testing, whereas clinical indications (e.g., abnormal liver function tests or liver-related symptoms such as jaundice) were cited by 2,121 (45.2%), suggesting that many HCV infections were identified only after the patient had become symptomatic. Promoting U.S. Preventive Services Task Force and CDC recommendations for testing and identifying strategies that help physicians implement HCV testing in their offices might help facilitate timely identification of HCV infection and reduce morbidity and mortality. Back to top EDUCATION AND TRAINING New Jersey Immunization Network to offer August 28 webinar on perinatal hepatitis B prevention The New Jersey Immunization Network will present a 30-minute webinar about perinatal hepatitis B prevention, beginning at 1:00 p.m. (ET) on August 28. The webinar will feature Dr. Deborah L. Wexler, executive director, Immunization Action Coalition (IAC), talking about IAC's hepatitis birth dose initiative, Give birth to the end of Hep B, and related online guide, Hepatitis B: What Hospitals Need to Do to Protect Newborns. Access additional information on webinar content, as well as the registration form Do you have a hepatitis B birth dose question for Dr. Wexler? Submit your question with your webinar registration, or email it to Mary Jo Garofoli, program coordinator. Back to top Vaccine Education Center plans September 11 webinar on rotavirus and intussusception The Vaccine Education Center (VEC) at Children's Hospital of Philadelphia will present a free one-hour webinar, beginning at noon (ET) on September 11. Part of its Current Issues in Vaccines series, Rotavirus and Intussusception: What Do We Know Now? will feature Paul Offit, MD, director of VEC. Registration (required) is open now. Back to top  |
About IZ Express
IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer
ISSN 2771-8085
IZ Express Disclaimer
ISSN 2771-8085
Editorial Information
-
Editor-in-ChiefKelly L. Moore, MD, MPH
-
Managing EditorJohn D. Grabenstein, RPh, PhD
-
Associate EditorSharon G. Humiston, MD, MPH
-
Writer/Publication CoordinatorTaryn Chapman, MS
Courtnay Londo, MA -
Style and Copy EditorMarian Deegan, JD
-
Web Edition ManagersArkady Shakhnovich
Jermaine Royes -
Contributing WriterLaurel H. Wood, MPA
-
Technical ReviewerKayla Ohlde